BME Introduces Surgeon Advisory Board For The Upper Extremity Market

SAN ANTONIO, Feb. 24, 2015 /PRNewswire/ -- BioMedical Enterprises (BME) is pleased to announce the creation of its Hand and Wrist Surgeon Advisory Board.  This new team will use their collective experience to guide BME's product pipeline and ensure that these products live up to the quality and efficiency standards which are synonymous with BME. As thought leaders, they will also support BME in educating other physicians on the benefits of Nitinol technologies and lead various research initiatives. These physicians, chosen for their expertise in the field, will help BME achieve greater breadth and depth of product offering in the upper extremity market.

Keith Peeples, BME President and CEO stated, "BME is honored to have this world class group of physicians as part of our advisory team. Along with our foot and ankle consultants, this group of upper extremity surgeons will help BME forge its path into a leadership position in the extremity market."

 The BME Hand and Wrist Surgeon Advisory Board members:

• David Beard, M.D. – Orthopaedic Surgeon, Department of Orthopedic Surgery, Essentia Health Care System; Fargo, ND.
• R. Glenn Gaston, M.D. – Chief of Hand Surgery, Carolinas Medical Center, Hand Fellowship Director, OrthoCarolina; Charlotte, NC.
• Jeffrey Greenberg, M.D., M.S. – Partner, Indiana Hand to Shoulder Center, Clinical Assistant Professor, Indiana University Department of Orthopedic Surgery; Indianapolis, IN.
• Steve K. Lee, M.D. – Associate Professor of Orthopaedic Surgery Hand, Upper Extremity, and Microsurgery Director of Research, Center for Brachial Plexus and Traumatic Nerve Injury, Hospital for Special Surgery (HSS), Weill Medical College of Cornell University; New York, NY.
• Jeffrey Yao, M.D. – Associate Professor of Orthopaedic Surgery and Surgery Robert A. Chase Hand and Upper Limb Center, Stanford University Medical Center; Redwood City, CA.

About BME, Inc.

BME, Inc. is a privately-held leader in orthopedic shape memory implant technology for small bone fixation and the only U.S. manufacturer of Nitinol metal implants for musculoskeletal and soft tissue fixation. 

For over a decade, BME has spearheaded the innovation of the Nitinol technologies in the U.S. market, and continues the advancement of Nitinol implants and instruments.  This is accomplished by BME developing new standards for manufacturing processes, adding to its surgeon advisory boards, and focusing on the education of our surgeon communities on the clinical benefits of the Nitinol technology.  Innovation and strategic partnerships will further define the role of BME as leaders, as demonstrated in our commitment to the BME surgeon and patients.

For more information about this announcement and/or BME, Inc., please contact Rich Adelson, Vice President of Business Development and Marketing at: [email protected] or call 800-880-6528.

SOURCE BME, Inc.

Related Links

http://www.bme-tx.com